Cytovene (ganciclovir) / Roche 
Welcome,         Profile    Billing    Logout  
 268 Diseases   30 Trials   30 Trials   2139 News 


«12345678910111213...3536»
  • ||||||||||  paclitaxel / Generic mfg.
    A case of Kaposi sarcoma with pulmonary metastasis: successful management with Paclitaxel (e-Poster Hall) -  Aug 30, 2023 - Abstract #EADV2023EADV_3339;    
    Some of the chemotherapy drugs used to treat include Vincristine, Bleomycin, Etoposide, pegylated Doxorubicin or Daunorubicin either alone or in combination with Paclitaxel as a second-line therapy. We present a case of KS with pulmonary metastasis successfully managed with Paclitaxel.
  • ||||||||||  Cytovene (ganciclovir) / Roche
    Journal:  Autofluorescent Artemisinin-Benzimidazole Hybrids via (Pubmed Central) -  Aug 28, 2023   
    These results suggest that higher ganciclovir trough concentrations are associated with an increased risk of leukopenia grade 3 or higher, and that creatinine clearance and lung re-transplantation affected the pharmacokinetics of ganciclovir. All newly prepared fluorescent compounds showed strong anti-HCMV activity (EC down to 0.07
  • ||||||||||  Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe, Cytovene (ganciclovir) / Roche
    Journal:  The Multifaceted Clinical Characteristics of Congenital Cytomegalovirus Infection: From Pregnancy to Long-Term Outcomes. (Pubmed Central) -  Aug 20, 2023   
    Our data show that prenatal findings including maternal serologic tests and ultrasound have limited ability to detect congenital CMV in Korea. Given that CMV is associated with high rates of developmental delay and hearing loss in infants, there is an urgent need to develop specific strategies for the definite diagnosis of congenital CMV infection during the perinatal period by a multidisciplinary approach to decrease the risks of neurologic impairment and hearing loss through early antiviral treatment.
  • ||||||||||  Cytovene (ganciclovir) / Roche, navitoclax (ABT 263) / AbbVie
    Journal:  Cellular Senescence Contributes to Large Elastic Artery Stiffening and Endothelial Dysfunction With Aging: Amelioration With Senolytic Treatment. (Pubmed Central) -  Aug 18, 2023   
    Given that CMV is associated with high rates of developmental delay and hearing loss in infants, there is an urgent need to develop specific strategies for the definite diagnosis of congenital CMV infection during the perinatal period by a multidisciplinary approach to decrease the risks of neurologic impairment and hearing loss through early antiviral treatment. Cellular senescence and the SASP contribute to vascular aging, and senolytics hold promise for improving age-related vascular function.
  • ||||||||||  Cytovene (ganciclovir) / Roche
    Journal:  Can Ganciclovir and Quercetin-P188 Ameliorate Cytomegalovirus Induced Hearing Loss? (Pubmed Central) -  Aug 17, 2023   
    Combining GCV with the excipients quercetin and P188 effectively ameliorated CMV-induced sensorineural hearing loss in a murine model. This result may be partially explained by a reduction in viral titers in mouse temporal bones that correlate with in vitro studies demonstrating additive antiviral effect in cell culture.
  • ||||||||||  Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe, Cytovene (ganciclovir) / Roche
    Journal:  Acute Retinal Necrosis: Experience in a Reference Center in Santander - Colombia. (Pubmed Central) -  Aug 15, 2023   
    Our findings emphasize effective treatment strategies' role in visual prognosis. ACV: Acyclovir; BCVA: Best Corrected Visual Acuity; CMV: Cytomegalovirus; EBV: Epstein Barr Virus; FTA-ABS: Fluorescent treponemal antibody absorption test; HSV 1-2: Herpes simplex virus 1-2; HIV: Human Immunodeficiency Virus; IV-ACV: Intravenous- Acyclovir; PCR: Polymerase Chain Reaction;Tg: Toxoplasma gondii; VZV: Varicella Zoster Virus; VCV: Valacyclovir; VDRL: Venereal disease research laboratory test.
  • ||||||||||  Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe, Cytovene (ganciclovir) / Roche
    Trial primary completion date:  STACCATO: Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes (clinicaltrials.gov) -  Aug 14, 2023   
    P2/3,  N=99, Recruiting, 
    ACV: Acyclovir; BCVA: Best Corrected Visual Acuity; CMV: Cytomegalovirus; EBV: Epstein Barr Virus; FTA-ABS: Fluorescent treponemal antibody absorption test; HSV 1-2: Herpes simplex virus 1-2; HIV: Human Immunodeficiency Virus; IV-ACV: Intravenous- Acyclovir; PCR: Polymerase Chain Reaction;Tg: Toxoplasma gondii; VZV: Varicella Zoster Virus; VCV: Valacyclovir; VDRL: Venereal disease research laboratory test. Trial primary completion date: Oct 2023 --> Mar 2024
  • ||||||||||  Ozurdex (dexamethasone intravitreal implant) / AbbVie
    Journal:  Dexamethasone intravitreal implant for macular edema and some other rare indications in uveitis. (Pubmed Central) -  Aug 10, 2023   
    Retinal detachment occurred in one eye (0.9%), endophthalmitis in one eye (0.9%), and transient intravitreal hemorrhage occurred in three eyes (2.7%) after the IDI injections. On the whole, the present study demonstrates that although IDI is mostly employed in non-infectious uveitic eyes with macular edema, it can also be administered in cases with systemic therapy intolerance, pseudophakic macular edema prophylaxis, and with great caution, in selected cases involving infectious uveitis and macular edema.
  • ||||||||||  Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe, Cytovene (ganciclovir) / Roche
    CMV Ileitis in an Immunocompetent Patient (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_4610;    
    Early recognition, diagnosis, and initiation of therapy is crucial to preventing further spread and complications. Figure: Endoscopic images of the terminal ileum demonstrating inflammation with erythematous and friable mucosa.
  • ||||||||||  Cytovene (ganciclovir) / Roche
    Concurrent CMV Colitis and Gastric Kaposi Sarcoma in AIDS Patient Presenting as Watery Diarrhea (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_3614;    
    Patient improved significantly with intravenous ganciclovir and was followed-up outpatient by oncology for the treatment of Kaposi sarcoma...Figure: A. EGD demonstrating gastric body violaceous nodule. B & C. Colonoscopy demonstrating multiple scattered irregular ulcerations with edema and erythema.
  • ||||||||||  Cytovene (ganciclovir) / Roche
    Pancreas Re  (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_3407;    
    All antibiotics were discontinued, and prednisone 80 mg was started due to suspected DRESS relapse based on increasing eosinophilia and skin desquamation...Ganciclovir treatment was initiated, improving liver function, leukocytosis, and fever...This case emphasizes the importance of considering DRESS in patients with unique and rare clinical manifestations, including pancreatitis. Figure: Trends of WBC and Eosinophils in hospital stay
  • ||||||||||  Humira (adalimumab) / AbbVie
    Use of Adalimumab During a Crohn (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_2728;    
    Further research and studies in this area is warranted to guide clinical decision making to optimize patient care. Figure: Proctoscopy images showing severe colitis with deep ulceration and fistula formation within the first five centimeters.
  • ||||||||||  Cytovene (ganciclovir) / Roche
    Acute CMV Colitis in a Patient With Crohn (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_2722;    
    Figure: Proctoscopy images showing severe colitis with deep ulceration and fistula formation within the first five centimeters. He was started on ganciclovir with resolution of fever...Pylephlebitis typically resolves with treatment of underlying infection and the patients don
  • ||||||||||  Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe, Cytovene (ganciclovir) / Roche, Humira (adalimumab) / AbbVie
    A Therapeutic Conundrum: Ulcerative Colitis Flare With Concomitant CMV Colitis (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_2720;    
    Case Description/ A 56-year-old male with a known history of UC on adalimumab presents with intractable, non-bloody watery diarrhea, and recurrent subjective fevers over the past week after returning from a cruise to Puerto Rico...Symptoms persisted despite a 10-day course of piperacillin-tazobactam...The patient was started on IV ganciclovir, but continued to have recurrent daily fevers and persistent diarrhea...He was eventually discharged on home oral valganciclovir and oral high-dose steroids...Steroids are generally avoided in infectious management, however our patient required high dose steroids in addition to antivirals to counteract an ongoing UC flare. This multimodal treatment regimen optimized our patient's response to simultaneous colitis etiologies.
  • ||||||||||  Cytovene (ganciclovir) / Roche
    Navigating the Clinical Challenges: CMV Gastroenteritis in a Cardiac Sarcoidosis Patient on Immunosuppression and Concurrent COVID-19 Infection (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_2196;    
    Notably, the patient was on immunosuppressive therapy with mycophenolate and methotrexate, which were discontinued upon admission...Concurrently, he was diagnosed with asymptomatic COVID-19 and received a five-day course of remdesivir.He was started on intravenous ganciclovir, but his condition deteriorated, leading to a cardiac arrest from which he could not be resuscitated...Although the patient was asymptomatic for COVID-19, its potential impact on his immune status could have affected the course and management of CMV gastroenteritis. Figure: Gastrointestinal endoscopy revealed Barrett's esophagus, gastric erosions, and gastric polyps.
  • ||||||||||  Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe, Cytovene (ganciclovir) / Roche
    You Can't Always Trust Your Gut: CMV Colitis in an Immunocompetent Patient With COVID-19 (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_2101;    
    While there are several known risk factors associated with CMV colitis amongst immunocompetent patients, a possible connection between COVID-19 with CMV colitis should be investigated. Figure: Colonoscopy showed severe inflammation in the descending colon
  • ||||||||||  Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe, Cytovene (ganciclovir) / Roche
    Cytomegalovirus Colitis Presenting as an Obstructing Mass in an Immunocompetent Host (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_2100;    
    Figure C: Immunohistochemical staining of sigmoid mass showing positivity for CMV. Figure D: Repeat colonoscopy showing inflammation without a discrete mass in the sigmoid colon.
  • ||||||||||  Cytovene (ganciclovir) / Roche
    I Spy With My Owl's Eye: Gastrointestinal Cytomegalovirus (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_1855;    
    Figure: Histopathological and endoscopic pictures of cytomegalovirus gastritis. Note many non-bleeding cratered gastric ulcers with a clean ulcer base (Forrest Class III) and numerous areas of patchy erythema in the gastric body; Histopathological examination of the erythema showing large epithelial cells with characteristic
  • ||||||||||  Cytovene (ganciclovir) / Roche
    Cytomegalovirus Duodenitis Causing Partial Small Bowel Obstruction in the Setting of Diffuse Large B-Cell Lymphoma (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_1734;    
    In our case, there was an improvement in both observed symptoms of small bowel obstruction and cytomegalovirus quantitative PCR level with intravenous Ganciclovir therapy, which may reflect a possible association between levels of viral load and activity of cytomegalovirus duodenitis. Figure: Benign Duodenal Stricture Noted in the Second Part of Duodenum With Edematous Submucosa Near Obstruction of the Lumen
  • ||||||||||  Ocrevus (ocrelizumab) / Roche, Biogen
    Ocrelizumab Induced Colitis: A Rare Clinical Entity Mimicking Cytomegalovirus Colitis (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_791;    
    Ganciclovir was started while awaiting biopsy results, without improvement...Her diarrhea improved and she was discharged on 2-week course of prednisone, along with as needed loperamide...It also predisposes to CMV colitis; therefore, endoscopic assessment with biopsies should be encouraged in patients with new onset gastrointestinal symptoms while on treatment, to provide an accurate and timely diagnosis. Figure: Punched out ulcers in colon
  • ||||||||||  Opdivo (nivolumab) / Ono Pharma, BMS
    Double Whammy: A Case Report of Immune Checkpoint Inhibitor Colitis and Concomitant CMV Colitis in a Patient on Nivolumab for Metastatic Melanoma (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_721;    
    Agents including nivolumab and ipilimumab have been shown to cause diarrhea due to colitis and/or enteritis in up to 40% of patients...ICI was held and he was started on prednisone with suspicion for immune-mediated diarrhea...IV methylprednisolone was started...The patient was started on a 3-week course of IV ganciclovir and Bactrim for PJP prophylaxis...Infliximab and vedolizumab can be used in steroid-refractory cases, though caution must be employed in the setting of active infection...C: Crypt abscesses with marked attenuation of colonic epithelium. D: Immunohistochemical stain for cytomegalovirus, demonstrating the presence of several CMV positive cells within an inflammatory polyp.
  • ||||||||||  Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J, Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe, Cytovene (ganciclovir) / Roche
    Tacrolimus Used to Manage Treatment Refractory Immune Checkpoint Inhibitor Colitis: A Case Report (Exhibit Hall) -  Jul 29, 2023 - Abstract #ACG2023ACG_694;    
    A trial of ganciclovir 240mg q12h for possible cytomegalovirus (CMV) infection and methylprednisolone 2mg/kg daily were begun...After completing a course of vancomycin, the patient was discharged to continue treatment with tacrolimus and valganciclovir for treatment refractory ICI colitis and concomitant CMV infection...Although no clinical trials exist, the administration of tacrolimus medical therapy could be considered prior to surgical intervention for treatment refractory ICI colitis. Figure: ICI colitis refractory to infliximab and tofacitinib and eventually only responded to tacrolimus